HIV/AIDS
Report summarizes HIV/AIDS study findings from T.J. Podsadecki and co-researchers
Published in AIDS Weekly, February 18th, 2008
Researchers in the United States conducted a study "To identify potential causes and clinical implications of transient increases in plasma viral load (hereafter, ''blips''). M99-056 and M02-418 were prospective, randomized trials evaluating the safety and efficacy of lopinavir/ ritonavir (LPV/r) capsules administered twice per day or once per day to subjects infected with human immunodeficiency virus-1 (HIV-1)."
"Plasma viral load was measured every 4 weeks (from baseline through week 24, excluding week 12 and week 20 in M02-418), every 8 weeks (from week 24 through week 48), and every 12 weeks (from week 48 through week 96). Blips were defined by 1 plasma viral load...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-02-18)
More Articles from AIDS Weekly
- HIV/AIDS
Anti-parasite drug may provide new way to attack HIV - HIV/AIDS
Mane event: Recombination in lion feline immunodeficiency virus - HIV/AIDS
Research from S.H. Yap et al broadens understanding of HIV/AIDS - HIV/AIDS
Studies from Harvard University have provided new data on HIV/AIDS - HIV/AIDS Cancer
New data from Chelsea and Westminster Hospital NHS Trust illuminate research in HIV/AIDS cancer - HIV/AIDS Cancer
Recent studies from University of Barcelona add new data to HIV/AIDS cancer - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
